351 related articles for article (PubMed ID: 20042458)
1. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
[TBL] [Abstract][Full Text] [Related]
2. Effects of combination PPARγ agonist and angiotensin receptor blocker on glomerulosclerosis.
Matsushita K; Yang HC; Mysore MM; Zhong J; Shyr Y; Ma LJ; Fogo AB
Lab Invest; 2016 Jun; 96(6):602-9. PubMed ID: 26999660
[TBL] [Abstract][Full Text] [Related]
3. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
[TBL] [Abstract][Full Text] [Related]
4. Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2).
Day RT; Cavaglieri Rde C; Tabatabaimir H; Mantravadi V; Lee MJ; Barnes JL; Kasinath BS; Feliers D
Cell Signal; 2010 Dec; 22(12):1849-57. PubMed ID: 20667471
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
Mii A; Shimizu A; Masuda Y; Ishizaki M; Kawachi H; Iino Y; Katayama Y; Fukuda Y
Lab Invest; 2009 Feb; 89(2):164-77. PubMed ID: 19139720
[TBL] [Abstract][Full Text] [Related]
6. Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response.
Esteban V; Ruperez M; Vita JR; López ES; Mezzano S; Plaza JJ; Egido J; Ruiz-Ortega M
Kidney Int Suppl; 2003 Oct; (86):S33-8. PubMed ID: 12969125
[TBL] [Abstract][Full Text] [Related]
7. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
Zhuo J; Ohishi M; Mendelsohn FA
Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease.
Xu C; Ding W; Zhang M; Gu Y
Nephrology (Carlton); 2013 Dec; 18(12):761-9. PubMed ID: 23901805
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II.
Galindo M; Santiago B; Palao G; Gutierrez-Cañas I; Ramirez JC; Pablos JL
Peptides; 2005 Sep; 26(9):1647-53. PubMed ID: 16112405
[TBL] [Abstract][Full Text] [Related]
10. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
[TBL] [Abstract][Full Text] [Related]
11. [The influence of angiotensin II receptor blockade on the expressions of Col I and TIMP-1 mRNA in cardiac fibroblast of adult rat].
Jiang XY; Gao GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):954-7. PubMed ID: 18095594
[TBL] [Abstract][Full Text] [Related]
12. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.
Ma LJ; Nakamura S; Aldigier JC; Rossini M; Yang H; Liang X; Nakamura I; Marcantoni C; Fogo AB
J Am Soc Nephrol; 2005 Apr; 16(4):966-76. PubMed ID: 15728787
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
Chen K; Mehta JL; Li D; Joseph L; Joseph J
Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
[TBL] [Abstract][Full Text] [Related]
14. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats.
Gigante B; Piras O; De Paolis P; Porcellini A; Natale A; Volpe M
J Hypertens; 1998 Dec; 16(12 Pt 2):2039-43. PubMed ID: 9886894
[TBL] [Abstract][Full Text] [Related]
15. Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.
Siragy HM; El-Kersh MA; De Gasparo M; Webb RL; Carey RM
J Hypertens; 2002 Jun; 20(6):1157-63. PubMed ID: 12023686
[TBL] [Abstract][Full Text] [Related]
16. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Whaley-Connell A; Nistala R; Habibi J; Hayden MR; Schneider RI; Johnson MS; Tilmon R; Rehmer N; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F655-61. PubMed ID: 20007350
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
[TBL] [Abstract][Full Text] [Related]
18. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system.
Macari D; Whitebread S; Cumin F; De Gasparo M; Levens N
Eur J Pharmacol; 1994 Jun; 259(1):27-36. PubMed ID: 7957590
[TBL] [Abstract][Full Text] [Related]
19. Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
Kim HJ; Sato T; Rodríguez-Iturbe B; Vaziri ND
J Pharmacol Exp Ther; 2011 Jun; 337(3):583-90. PubMed ID: 21357516
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-Related Mechanisms Underlying Survival Benefit of Long-Term Angiotensin Receptor Blocker.
Zhu X; Gao D; Albertazzi V; Zhong J; Ma LJ; Du L; Shyr Y; Kon V; Yang HC; Fogo AB
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
